Endospan Overview

  • Founded
  • 2009

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $450M

  • Investors
  • 1

Endospan General Information

Description

Developer of an aortic stent-grafts system designed to treat aneurysms, dissections and aortic lesions. The company's aortic stent-grafts system offers invasive endovascular services and differentiated aortic endografts to address underserved clinical needs and patients' subgroups, enabling patients diagnosed with an aneurysm to get proper treatment.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Parent Company
Primary Office
  • Maskit Street 4
  • Herzlia Business Park
  • Herzlia 46733
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endospan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Sep-2019 $450M 0000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 21-Oct-2015 0000 0000 00000 Completed Generating Revenue
1. Early Stage VC 27-Sep-2011 $15M $15M Completed Generating Revenue
To view Endospan’s complete valuation and funding history, request access »

Endospan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an aortic stent-grafts system designed to treat aneurysms, dissections and aortic lesions. The company's ao
Surgical Devices
Herzlia, Israel
40 As of 2015
0000
0000 0000-00-00
000000&0 0000

000000

etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
00000000 0000000
Wayne, PA
00 As of 0000
000.00
000000&0 000.00

000000

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
00000000 0000000
Plymouth, MN
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endospan Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vesper Medical Venture Capital-Backed Wayne, PA 00 000.00 000000&0 000.00
0000000000 00000 Venture Capital-Backed Plymouth, MN 00 000.00 0000000000 0 000.00
00000000 00000000 Corporate Backed or Acquired South Jordan, UT 000000&0
00 000000 Formerly VC-backed Milpitas, CA 00 00000 000000&0 00000
0000000 0000000 Formerly PE-Backed Didcot, United Kingdom 000 00000 000000&0
You’re viewing 5 of 13 competitors. Get the full list »

Endospan Patents

Endospan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200107925-A1 Stent-grafts for sealing around external disturbances Abandoned 21-Mar-2017 00000000
JP-2020512914-A Stent graft for sealing around external disturbances Pending 21-Mar-2017 00000000
EP-3600148-A1 Stent-grafts for sealing around external disturbances Pending 21-Mar-2017 00000000
US-10905540-B2 Stent-grafts systems with skirt Active 12-Nov-2015 00000000 00
CA-3004821-A1 Stent-grafts systems with skirt Pending 12-Nov-2015 A61F2/07
To view Endospan’s complete patent history, request access »

Endospan Executive Team (8)

Name Title Board Seat Contact Info
Kevin Mayberry Chief Executive Officer
Eli Gendler Chief Financial Officer
Sagi Raz Ph.D Chief Technology Officer
Ami Catz Vice President of Operations
Yaniv Marmur Vice President of Research & Development
You’re viewing 5 of 8 executive team members. Get the full list »

Endospan Board Members (8)

Name Representing Role Since
Alon Shalev Self Co-FOunder, Vice President of Business Development and Board Member 000 0000
You’re viewing 1 of 8 board members. Get the full list »

Endospan Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endospan Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelmed Ventures Venture Capital Minority 000 0000 000000 0
Arkin Holdings Venture Capital Minority 000 0000 000000 0
Haisco Pharmaceutical Group Company Corporation Minority 000 0000 000000 0
Haisthera Scientific Fund Corporation Minority 000 0000 000000 0
SCP Vitalife Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »